A high-purity double virus inactivated FVIII/vWF concentrate (Immunate) in the successful treatment of patients with von Willebrand disease

MLA

G. Pindur, et al. “A High-Purity Double Virus Inactivated FVIII/VWF Concentrate (Immunate) in the Successful Treatment of Patients with von Willebrand Disease.” Haemophilia, vol. 8, Oct. 2002, p. 836. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a3d80ba19be3ac5448d3130966be6242&authtype=sso&custid=ns315887.

APA

G. Pindur, C Günther, Wolfhart Kreuz, B Eifrid, H‐H Wolf, Werner Engl, A Nitz, Peter Turecek, G. Auerswald, Jürgen Siekmann, H. Scheel, JD Schrieber, Inge Scharrer, Bruno Eberspächer, & M Koksch. (2002). A high-purity double virus inactivated FVIII/vWF concentrate (Immunate) in the successful treatment of patients with von Willebrand disease. Haemophilia, 8, 836.

Chicago

G. Pindur, C Günther, Wolfhart Kreuz, B Eifrid, H‐H Wolf, Werner Engl, A Nitz, et al. 2002. “A High-Purity Double Virus Inactivated FVIII/VWF Concentrate (Immunate) in the Successful Treatment of Patients with von Willebrand Disease.” Haemophilia 8 (October): 836. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a3d80ba19be3ac5448d3130966be6242&authtype=sso&custid=ns315887.